Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Peering Into Koss Corporation's Recent Short Interest

Koss Corporation's (NASDAQ:KOSS) short percent of float has fallen 18.13% since its last report. The company recently reported that it has 114.40 thousand shares sold short, which is 2.62% of all regular shares that are available for trading.

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022

Upgrades For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and a 52-week-low of $7.66. E2open Parent Holdings closed at $9.37 at the end of the last trading period.

Looking Into Mondelez International Inc - Class A's Recent Short Interest

Looking Into Mondelez International Inc - Class A's Recent Short Interest

Mondelez International Inc - Class A's (NASDAQ:MDLZ) short percent of float has risen 29.87% since its last report. The company recently reported that it has 13.90 million shares sold short, which is 1.0% of all regular shares that are available for trading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

YouTube Takes On Streaming, TV With Expanded Selection Of Free Programming

Alphabet Inc.’s (NASDAQ: GOOGL) (NASDAQ: GOOG) YouTube online video platform is taking aim at streaming services and over-the-air television by making nearly 4,000 episodes of popular television series and s

Locafy Limited To Start Trading Tomorrow

Locafy Limited (NASDAQ:LCFY) IPO will take place March, 24 on the NASDAQ exchange under the ticker LCFY. The company is offering shares at an expected price between $4.50 and $6.50 per share with an insider lock-up period of 180 days ending on September 20, 2022.

$1000 Invested In Koss 5 Years Ago Would Be Worth This Much

Koss (NASDAQ:KOSS) has outperformed the market over the past 5 years by 22.12% on an annualized basis producing an average annual return of 35.81%. Currently, Koss has a market capitalization of $90.29 million.

Absci's Return On Capital Employed Overview

Absci (NASDAQ:ABSI) brought in sales totaling $1.45 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 6.48%, resulting in a loss of $25.17 million.

inkl

Read news from The Economist, FT, and more,
with one subscription

Gulf Island Fabrication's Return On Capital Employed Insights

Gulf Island Fabrication's Return On Capital Employed Insights

Gulf Island Fabrication (NASDAQ:GIFI) brought in sales totaling $25.81 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 210.84%, resulting in a loss of $5.89 million.

Looking Into Codex DNA's Return On Capital Employed

Looking Into Codex DNA's Return On Capital Employed

Benzinga Pro data, Codex DNA (NASDAQ:DNAY) reported Q4 sales of $3.08 million. Earnings fell to a loss of $12.49 million, resulting in a 27.15% decrease from last quarter.

Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study

Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study

Creative Medical Technology Holdings (NASDAQ:CELZ) has announced positive two-year follow-up data from its StemSpine pilot study. The data showed significant efficacy of the StemSpine procedure for treating chronic lower back pain without any serious adverse effects reported. StemSpine is a patented procedure that utilizes a patient's bone marrow aspirate to treat chronic lower…

Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity

Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity

Allogene Therapeutics Inc (NASDAQ: ALLO) announced the

MaxCyte's Return On Capital Employed Insights

MaxCyte's Return On Capital Employed Insights

Benzinga Pro data, MaxCyte (NASDAQ:MXCT) reported Q4 sales of $10.15 million. Earnings fell to a loss of $4.87 million, resulting in a 81.85% decrease from last quarter.

Exagen's Return On Capital Employed Overview

Exagen's Return On Capital Employed Overview

According to Benzinga Pro data, during Q4, Exagen (NASDAQ:XGN) posted sales of $12.69 million. Earnings were up 1.76%, but Exagen still reported an overall loss of $7.05 million.

DarioHealth's Return On Capital Employed Overview

DarioHealth's Return On Capital Employed Overview

According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21.59 million.

Get all your
news in one place.

100's of premium titles.
One news app.

Ondas Holdings Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q4, Ondas Holdings's (NASDAQ:ONDS) reported sales totaled $571.25 thousand. Despite a 15.56% increase in earnings, the company posted a loss of $4.15 million.

FreightCar America's Return On Capital Employed Overview

According to Benzinga Pro, during Q4, FreightCar America (NASDAQ:RAIL) earned $1.17 million, a 59.37% increase from the preceding quarter. FreightCar America also posted a total of $75.02 million in sales, a 28.66% increase since Q3.

Why Creative Medical Technology Shares Are Soaring

Creative Medical Technology Holdings Inc (NASDAQ: CELZ) shares are trading higher Wednesday after the company announced top-line results for its follow-up StemSpine pilot study.

Mid-Morning Market Update: Markets Open Lower; General Mills Posts Upbeat Earnings

U.S. stocks opened on downbeat note this morning, with the Dow Jones dropping more than 250 points on Wednesday.

Get all your
news in one place.

100's of premium titles.
One news app.

Recap: Agrify Q4 Earnings

Agrify (NASDAQ:AGFY) reported its Q4 earnings results on Wednesday, March 23, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

GreenPower Launches Electric School Bus, Nano BEAST

GreenPower Motor Company Inc (NASDAQ:GP) has launched a purpose-built, battery-electric, Type A school bus, Nano BEAST. The school bus has a range of up to 150 miles per charge. "The school bus industry is the largest form of transportation in the U.S. with more than 25 million students transported daily," said GreenPower…

Benzinga's Daily Brief On Trending Tickers For March 23, 2022: GameStop, Koss, Tesla And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.

4D Pharma Shares Soar On MRx0518/Keytruda Combo Trial Data In Renal Cell Carcinoma

4D pharma plc (NASDAQ:LBPS) has announced interim results from Phase 1/2 study evaluating the combination of MRx0518 and Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) for renal cell carcinoma (RCC). The Part B of its signal finding study of MRx0518 & Keytruda combo in solid tumors that have progressed on a prior immune checkpoint inhibitor…

Analyzing SolarEdge Technologies Inc. - Common Stock's Short Interest

SolarEdge Technologies Inc. - Common Stock's (NASDAQ:SEDG) short percent of float has risen 8.51% since its last report. The company recently reported that it has 1.58 million shares sold short, which is 3.06% of all regular shares that are available for trading.

Why Poshmark Shares Are Falling Today

Poshmark Inc (NASDAQ: POSH) shares are trading lower Wednesday after the company reported worse-than-expected earnings results and issued guidance below estimates.

11 Industrials Stocks Moving In Wednesday's Pre-Market Session

1 … 814 815 816 817

Organisations

Paycom Software

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

378,674 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play